Global Metabolomics Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

The global metabolomics market size was valued at $1,585 million in 2018 and is expected to reach $3,800 Mn by 2026, growing at a CAGR of 14.7% during the forecast period 2019 to 2026.

The growth of the global metabolomics market is driven by rise in prevalence of chronic diseases worldwide, an upsurge in R&D investment for the development of metabolomics, and an increase in demand for personalized medicine. However, the lack of skilled professionals in the field along with the astronomical price of metabolomic instruments hampers market growth. Nonetheless, the immense potential of metabolomics in disease diagnostics and its growing prospect in human nutrition would create lucrative opportunities for emerging market players in the near future.

The report analyzes and forecasts the metabolomics market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global metabolomics market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the metabolomics market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of metabolomics market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Competitive Landscape is the most valuable part of this report

The key players analyzed in the report include Agilent Technologies, Inc., Danaher Corporation, Biocrates Life Sciences AG, Bruker Corporation, Leco Corporation, Metabolon, Inc., Human Metabolome Technologies, Inc., Bio-Rad Laboratories, Inc., Shimadzu Corporation, Waters Corporation, and Thermo Fisher Scientific Inc. They have adopted different strategies including collaborations, joint ventures, partnerships, expansions, mergers & acquisitions, and others to gain a strong position in the industry.

Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market.  This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the industries. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry.

Segmentation:

By Product & Service

  • Metabolomics Instruments
    • Separation Techniques
      • High-performance Liquid Chromatography
      • Gas Chromatography
      • Ultra-performance Liquid Chromatography
      • Capillary Electrophoresis.
    • Detection Techniques
      • Mass Spectrometry
      • Nuclear Magnetic Resonance Spectroscopy
      • Surface-based Mass Analysis
  • Metabolomics Bioinformatics Tools & Services
    • Bioinformatics Tools and Database
    • Bioinformatics Services

By Application

  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Others

By Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • The Netherlands
    • Norway
    • Russia
    • Sweden
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Chile
    • Columbia
    • Egypt
    • Iran
    • Israel
    • Turkey
    • Venezuela
    • Rest of LAMEA

Report coverage

  • Analysis Period: 2015 – 2026
  • Base Year: 2018
  • Forecast Data: 2019 – 2026
  • Regional Scope: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Report Coverage: Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global metabolomics capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Focuses on the key metabolomics manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Section 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Section 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Section 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growth in demand for personalized medicines
3.5.1.2. Upsurge in R&D investment for development of metabolomics
3.5.1.3. Rise in global incidences of chronic diseases

3.5.2. Restraints

3.5.2.1. High cost of metabolic instruments
3.5.2.2. Scarcity of skilled professionals

3.5.3. Opportunities

3.5.3.1. Immense potential in disease diagnostics
3.5.3.2. Emerging prospect in human nutrition

Section 4 METABOLOMICS MARKET, BY PRODUCT & SERVICES

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. METABOLOMICS INSTRUMENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Separation technique

4.2.4.1. Market size & forecast
4.2.4.2. High-Performance Liquid Chromatography

4.2.4.2.1. Market size & forecast

4.2.4.3. Gas Chromatography

4.2.4.3.1. Market size & forecast

4.2.4.4. Ultra-Performance Liquid Chromatography

4.2.4.4.1. Market size & forecast

4.2.4.5. Capillary Electrophoresis

4.2.4.5.1. Market size & forecast

4.2.5. Detection technique

4.2.5.1. Market size & forecast
4.2.5.2. Mass Spectrometry

4.2.5.2.1. Market size & forecast

4.2.5.3. Nuclear Magnetic Resonance Spectroscopy

4.2.5.3.1. Market size & forecast

4.2.5.4. Surface-Based Mass Analysis

4.2.5.4.1. Market size & forecast

4.3. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.3.4. Bioinformatics Tools

4.3.4.1. Market size & forecast

4.3.5. Databases and Bioinformatics Services

4.3.5.1. Market size & forecast

Section 5 METABOLOMICS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. BIOMARKER DISCOVERY

5.2.1. Market size & forecast

5.3. DRUG DISCOVERY

5.3.1. Market size & forecast

5.4. TOXICOLOGY TESTING

5.4.1. Market size & forecast

5.5. NUTRIGENOMICS

5.5.1. Market size & forecast

5.6. FUNCTIONAL GENOMICS

5.6.1. Market size & forecast

5.7. PERSONALIZED MEDICINE

5.7.1. Market size & forecast

5.8. OTHER APPLICATION

5.8.1. Market size & forecast

Section 6 METABOLOMICS MARKET, BY INDICATION

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. CANCER

6.2.1. Market size & forecast

6.3. CARDIOVASCULAR DISORDERS

6.3.1. Market size & forecast

6.4. NEUROLOGICAL DISORDERS

6.4.1. Market size & forecast

6.5. INBORN ERRORS OF METABOLISM

6.5.1. Market size & forecast

6.6. OTHER INDICATIONS

6.6.1. Market size & forecast

Section 7 METABOLOMICS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast
7.2.4. Market size & forecast

7.2.4.1. U.S. market size and forecast by product & services
7.2.4.2. U.S. market size and forecast by application
7.2.4.3. U.S. market size and forecast by indication
7.2.4.4. Canada market size and forecast by product & services
7.2.4.5. Canada market size and forecast by application
7.2.4.6. Canada market size and forecast by indication
7.2.4.7. Mexico market size and forecast by product & services
7.2.4.8. Mexico market size and forecast by application
7.2.4.9. Mexico market size and forecast by indication

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast
7.3.4. Market size & forecast

7.3.4.1. Germany market size and forecast by product & services
7.3.4.2. Germany market size and forecast by application
7.3.4.3. Germany market size and forecast by indication
7.3.4.4. France market size and forecast by product & services
7.3.4.5. France market size and forecast by application
7.3.4.6. France market size and forecast by indication
7.3.4.7. UK market size and forecast by product & services
7.3.4.8. UK market size and forecast by application
7.3.4.9. UK market size and forecast by indication
7.3.4.10. Italy market size and forecast by product & services
7.3.4.11. Italy market size and forecast by application
7.3.4.12. Italy market size and forecast by indication
7.3.4.13. Spain market size and forecast by product & services
7.3.4.14. Spain market size and forecast by application
7.3.4.15. Spain market size and forecast by indication
7.3.4.16. Netherlands market size and forecast by product & services
7.3.4.17. Netherlands market size and forecast by application
7.3.4.18. Netherlands market size and forecast by indication
7.3.4.19. Norway market size and forecast by product & services
7.3.4.20. Norway market size and forecast by application
7.3.4.21. Norway market size and forecast by indication
7.3.4.22. Russia market size and forecast by product & services
7.3.4.23. Russia market size and forecast by application
7.3.4.24. Russia market size and forecast by indication
7.3.4.25. Sweden market size and forecast by product & services
7.3.4.26. Sweden market size and forecast by application
7.3.4.27. Sweden market size and forecast by indication
7.3.4.28. Switzerland market size and forecast by product & services
7.3.4.29. Switzerland market size and forecast by application
7.3.4.30. Switzerland market size and forecast by indication
7.3.4.31. Rest of Europe market size and forecast by product & services
7.3.4.32. Rest of Europe market size and forecast by application
7.3.4.33. Rest of Europe market size and forecast by indication

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast

7.4.3.1. Japan market size and forecast by product & services
7.4.3.2. Japan market size and forecast by application
7.4.3.3. Japan market size and forecast by indication
7.4.3.4. China market size and forecast by product & services
7.4.3.5. China market size and forecast by application
7.4.3.6. China market size and forecast by indication
7.4.3.7. Australia market size and forecast by product & services
7.4.3.8. Australia market size and forecast by application
7.4.3.9. Australia market size and forecast by indication
7.4.3.10. India market size and forecast by product & services
7.4.3.11. India market size and forecast by application
7.4.3.12. India market size and forecast by indication
7.4.3.13. South Korea market size and forecast by product & services
7.4.3.14. South Korea market size and forecast by application
7.4.3.15. South Korea market size and forecast by indication
7.4.3.16. Taiwan market size and forecast by product & services
7.4.3.17. Taiwan market size and forecast by application
7.4.3.18. Taiwan market size and forecast by indication
7.4.3.19. Thailand market size and forecast by product & services
7.4.3.20. Thailand market size and forecast by application
7.4.3.21. Thailand market size and forecast by indication
7.4.3.22. New Zealand market size and forecast by product & services
7.4.3.23. New Zealand market size and forecast by application
7.4.3.24. New Zealand market size and forecast by indication
7.4.3.25. Rest of Asia-pacific market size and forecast by product & services
7.4.3.26. Rest of Asia-pacific market size and forecast by application
7.4.3.27. Rest of Asia-pacific market size and forecast by indication

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast

7.5.3.1. Brazil market size and forecast by product & services
7.5.3.2. Brazil market size and forecast by application
7.5.3.3. Brazil market size and forecast by indication
7.5.3.4. Saudi Arabia market size and forecast by product & services
7.5.3.5. Saudi Arabia market size and forecast by application
7.5.3.6. Saudi Arabia market size and forecast by indication
7.5.3.7. South Africa market size and forecast by product & services
7.5.3.8. South Africa market size and forecast by application
7.5.3.9. South Africa market size and forecast by indication
7.5.3.10. Chile market size and forecast by product & services
7.5.3.11. Chile market size and forecast by application
7.5.3.12. Chile market size and forecast by indication
7.5.3.13. Columbia market size and forecast by product & services
7.5.3.14. Columbia market size and forecast by application
7.5.3.15. Columbia market size and forecast by indication
7.5.3.16. Egypt market size and forecast by product & services
7.5.3.17. Egypt market size and forecast by application
7.5.3.18. Egypt market size and forecast by indication
7.5.3.19. Iran market size and forecast by product & services
7.5.3.20. Iran market size and forecast by application
7.5.3.21. Iran market size and forecast by indication
7.5.3.22. Israel market size and forecast by product & services
7.5.3.23. Israel market size and forecast by application
7.5.3.24. Israel market size and forecast by indication
7.5.3.25. Turkey market size and forecast by product & services
7.5.3.26. Turkey market size and forecast by application
7.5.3.27. Turkey market size and forecast by indication
7.5.3.28. Venezuela market size and forecast by product & services
7.5.3.29. Venezuela market size and forecast by application
7.5.3.30. Venezuela market size and forecast by indication
7.5.3.31. Rest of LAMEA market size and forecast by product & services
7.5.3.32. Rest of LAMEA market size and forecast by application
7.5.3.33. Rest of LAMEA market size and forecast by indication

Section 8 COMPANY PROFILES

8.1. AGILENT TECHNOLOGIES INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. BIOCRATES LIFE SCIENCES AG

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. BIO-RAD LABORATORIES, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. BRUKER CORPORATION

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. DANAHER CORPORATION

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance

8.6. HUMAN METABOLOME TECHNOLOGIES, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. LECO CORPORATION

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. METABOLON, INC.

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. SHIMADZU CORPORATION

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. WATERS CORPORATION

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers